Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-11.37
↓ 35% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-8.39
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -11.37 | -30.1% |
| 2024 | -8.74 | +1.4% |
| 2023 | -8.86 | +23.0% |
| 2022 | -11.51 | -29.1% |
| 2021 | -8.91 | -126.1% |
| 2020 | -3.94 | +40.6% |
| 2019 | -6.64 | -35.1% |
| 2018 | -4.92 | +6.1% |
| 2017 | -5.23 | +62.1% |
| 2016 | -13.82 | - |